Table 1.
A summary of the studies that assessed the prevalence of overweight and obesity in patients with narcolepsy.
| Study/Year Country | Study Design | No of Cases | Prevalence of Overweight (OW), Obesity (OB)%, or Mean BMI ± SD in Cases | No of Controls | Prevalence of Overweight (OW), Obesity (OB)%, or Mean BMI ± SD in Controls | p-Value |
|---|---|---|---|---|---|---|
| Filardi [19], 2020, Italy | Case-control | 38 | OW 28.95 OB 39.47 |
21 | OW 4.76 OB 28.57 |
<0.05 |
| Barateau [20], 2019, France | Case-control | 92 | OW 38.04 OB 23.91 |
109 | OW 27.52 OB 4.59 |
<0.000 |
| Vandi [21], 2019, Italy | Case-control | 27 | OW 62.96 OB 18.5 |
19 | OW 21.1 OB 21.1 |
0.010 |
| Drissi [22], 2018, Sweden | Case-control | 19 | 24.72 ± 6.37 | 17 | 21.22 ± 2.42 | 0.039 |
| Wang [23], 2016, China | Case-control | 65 | OW 26.15 OB 38.46 |
79 | OW 5.06 OB 3.80 |
0.002 <0.001 |
| Kovalska [24], 2016, Czech Republic |
Case-control | 42 | 31.47 ± 5.41 | 46 | 27.53 ± 6.11 | 0.0021 |
| Donadio [25], 2014, Italy |
Case-control | 19 | 25 ± 4 | 19 | 23 ± 3 | <0.05 |
| Dauvillers [26], 2012, France | Case-control | 50 | BMI 25.11 [17.01–38.30] | 42 | BMI 21.40 [18.30–29.10] | 0.0001 |
| Poli [27],2009, Italy | Case-control | 14 | 28 ± 4.4 | 14 | 24.2 ± 2.8 | 0.012 |
| Arnulf [28], 2006, France | Case-control | 93 | 27.6 ± 0.6 | 111 | 25.0 ± 0.4 | <0.05 |
| Dahmen [29], 2001, Germany | Case-control | 132 | 28.2 ± 5.5 | 104 | 24.5 ± 4.7 | <0.0001 |